Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Non Operating Investment Income (2023 - 2025)

Historic Non Operating Investment Income for Nuvation Bio (NUVB) over the last 3 years, with Q2 2025 value amounting to -$1000.0.

  • Nuvation Bio's Non Operating Investment Income rose 8571.43% to -$1000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $7000.0, marking a year-over-year decrease of 7407.41%. This contributed to the annual value of -$12000.0 for FY2024, which is 9136.69% up from last year.
  • According to the latest figures from Q2 2025, Nuvation Bio's Non Operating Investment Income is -$1000.0, which was up 8571.43% from $3000.0 recorded in Q1 2025.
  • Nuvation Bio's 5-year Non Operating Investment Income high stood at $44000.0 for Q4 2023, and its period low was -$99000.0 during Q2 2023.
  • Over the past 3 years, Nuvation Bio's median Non Operating Investment Income value was $1000.0 (recorded in 2024), while the average stood at -$5888.9.
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first plummeted by 19166.67% in 2024, then soared by 20000.0% in 2025.
  • Nuvation Bio's Non Operating Investment Income (Quarter) stood at $44000.0 in 2023, then plummeted by 88.64% to $5000.0 in 2024, then tumbled by 120.0% to -$1000.0 in 2025.
  • Its Non Operating Investment Income was -$1000.0 in Q2 2025, compared to $3000.0 in Q1 2025 and $5000.0 in Q4 2024.